Key facts
- Myma Medical’s last known valuation is $3.0M (Apr 2026).
- It has raised $470K; the latest was Later Stage VC ($190K) in Apr 2026.
- Notable investors include Deepbridge Capital, ICURe, LYVA Labs.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Myma Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Myma Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Myma Medical
Developer of an automated intracytoplasmic sperm injection system designed to support in vitro fertilization procedures. The company offers an automated system that performs sperm injection into eggs with controlled precision and consistency during IVF processes, enabling fertility clinics to improve procedure efficiency and maintain consistent outcomes in assisted
- Sector
- Healthcare
- HQ
- Liverpool, United Kingdom
- Founded
- 2020
- Employees
- 2
- Website
- mymamedical.com/
- Ownership
- Privately Held (backing)
Myma Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Myma Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Myma Medical in its N-PORT filings yet. We sweep new filings monthly.